Table 2.
Patient surgical variables for the TAU and COLP groups.
Surgical variables | TAU (n = 22) | COLP (n = 19) |
---|---|---|
| ||
No. of levels | 3.1 ± 1.3 | 3.5 ± 1.4 |
| ||
Duration of surgery (min) | 161 ± 49 | 168 ± 53 |
| ||
Blood loss during surgery (mL) | 710 ± 632 | 622 ± 629 |
| ||
Re-operation | 4 (19%) | 4 (21%) |
| ||
Spinal segments involved | ||
Cervical | 5 (23%) | 6 (32%) |
Thoracic | 1 (5%) | 1 (5%) |
Lumbar | 17 (77%) | 13 (68%) |
Sacral | 1 (5%) | 3 (16%) |
| ||
Surgical aspects involved | ||
Discectomy | 3 (14%) | 5 (26%) |
Laminectomy | 20 (91%) | 17 (90%) |
Fusion | 21 (96%) | 16 (84%) |
Other | 2 (9%) | 3 (16%) |
| ||
Indication(s) for surgery | ||
Spinal stenosis | 19 (86%) | 14 (74%) |
Spondylolisthesis | 13 (59%) | 10 (53%) |
Herniated disk | 1 (5%) | 2 (11%) |
Fracture | 3 (14%) | 1 (5%) |
Other | 9 (41%) | 9 (47%) |
| ||
Symptoms present at time of surgery | ||
Pain | 21 (96%) | 18 (95%) |
Weakness | 3 (14%) | 6 (32%) |
Numbness | 3 (14%) | 5 (26%) |
Other | 3 (14%) | 1 (5%) |
Data are given in either mean ± SD or n(percent). Treatment groups were balanced across all surgical variables.
COLP, conditioned open-label placebo; TAU, treatment as usual.